ClinicalTrials.gov, stem cells and pay-to-participate clinical studies
In this Regenerative Medicine perspective, Leigh Turner discusses whether better screening of clinical trials on ClinicalTrials.gov is required and what needs to be done to protect patients.
Please sign in or register for FREE to view this content
Sign in to RegMedNet
Register to RegMedNet – the regenerative medicine network
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.